The 4-pregnene and 5α-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion

Cancer Research

Volumn 60, Issue 4, 2000, Pages 936-943

  Wiebe, John P ^a   Muzia, David ^a   Hu, Juncai ^a   Szwajcer, David ^a   Hill, Scott A ^a   Seachrist, Jennifer L ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXY 5ALPHA PREGNAN 20 ONE; PREGNANE DERIVATIVE; PROGESTERONE; PROGESTERONE DERIVATIVE; STEROID 5ALPHA REDUCTASE;

ADULT; AGED; ARTICLE; BREAST CELL; BREAST TUMOR; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; METABOLITE; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROGESTERONE SYNTHESIS; BREAST; CELL CULTURE; CELL DIVISION; DRUG EFFECT; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; FEMALE; HUMANS; MIDDLE AGED; PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 0034651239     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Going, J. J., Anderson, T. J., Battersby, S., and MacIntyre, C. C. A. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am. J. Pathol., 130: 193-204, 1988.
2. Potten, C. S., Watson, R. J., Williams, G. T., Tickle, S., Roberts, S. A., Harris, M., and Howel, A. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer, 58: 163-170, 1988.
3. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
4. Horwitz, K. B., Wei, L. L., Sedlacek, S. M., and D'Arville, C. N. Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog. Horm. Res., 41: 249-316, 1985.
5. Santen, R. J., Manni, A., Harvey, H., and Redmond, C. Endocrine treatment of breast cancer in women. Endocr. Rev., 11: 221-265, 1990.
6. Anderson, T. J., Battersby, S., King, R. J. B., McPherson, K., and Going, J. J. Oral contraceptive use influences resting breast proliferation. Hum. Pathol., 20: 1139-1144, 1989.
7. Badwe, R. A., Gregory, W. M., Chaudary, M. A., Richards, M. A., Bentley, A. G., Rubens, R. D., and Fentiman, I. S. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 337: 1261-1264, 1991.
8. Saad, Z., Bramwell, V., Duff, J., Girotti, M., Jory, T., Heathcote, G., Turnbull, I., Garcia, B., and Stitt, L. Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br. J. Surg., 81: 217-220, 1994.
9. Veronesi, U., Luini, A., Mariani, L., Del Vecchio, M., Alvez, D., Androli, C., Giacobone, A., Merson, M., Pacetti, G., Raselli, R., and Saccozzi, R. Effect of menstrual phase on surgical treatment of breast cancer. Lancet, 343: 1545-1547, 1994.
10. Segaloff, A. Steroids and carcinogenesis. J. Steroid Biochem., 6: 171-175, 1975.
11. Welsch, C. W. Hormones and murine mammary tumorigenesis: an historical view. In: B. S. Leung (ed.). Hormonal Regulation of Mammary Tumors, pp. 1-29. Montreal, Canada: Eden Press, 1982.
12. Jabara, A. G. Effects of progesterone on 9, 10-dimethyl-1,2-benzanthracene-induced mammary tumours in Sprague-Dawley rats. Br. J. Cancer, 21: 418-429, 1967.
13. Luo S., Stojanovic. M., Labrie C., and Labrie, F. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats. Int. J. Cancer, 73: 580-586, 1997.
14. Braunsberg, H., Coldham, N. G., Leake, R. E., Cowan, S. K., and Wong, W. R. Action of a progesterone on human breast cancer cells: mechanism of growth stimulation and inhibition. Eur. J. Cancer Clin. Oncol., 23: 563-572, 1987.
15. Clark, C. L., and Sutherland, R. L. Progestin regulation of cellular proliferation. Endocr. Rev., 11: 266-302, 1990.
16. King, R. J. B. A discussion of the roles of estrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol Biol., 39: 811-818, 1991.
17. Cappelletti, V., Miodini, P., Fioravanti, L., and Di Fronzo, G. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Anti-cancer Res., 15: 2551-2556, 1995.
18. Musgrove, E. A., and Sutherland, R. L. Cell cycle control by steroid hormones. Semin. Cancer Biol., 5: 381-389, 1994.
19. Clarke, R., Skaar, T., Baumann, K., Leonessa, F., James, M., Lippman, J., Thompson, E. W., Freter, C., and Brunner, N. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res. Treat., 31: 237-248, 1994.
20. Kip1. Mol. Endocrinol., 11: 1593-1607, 1997.
21. Wiebe, J. P., Deline, C., Buckingham, K. D., Dave, V., and Stothers, J. B. Synthesis of the allylic gonadal steroids, 3α-hydroxy-4-pregnen-20-one and 3α-hydroxy-4-androsten-17-one, and of 3α-hydroxy-5α-pregnan-20-one. Steroids, 45: 39-51, 1985.
22. Wiebe, J. P., Dave, V., and Stothers, J. B. Synthesis and characteristics of allylic 4-pregnene-3.20-diols found in gonadal and breast tissue. Steroids, 47: 249-259, 1986.
23. Doussal, V. A., Tubiana-Uulin, M., Friedman, S., Hacene, K., Spyratoss, F., and Brunet, M. Prognostic value of histological grade nuclear components of Scarff-Bloom-Richardson (SBR). Cancer (Phila.), 64: 1914-1921, 1989.
24. Wiebe, J. P., Myers, K. I., and Auersperg, N. Modification of steroidogenesis in rat adrenocortical cells transformed by Kirsten Murine Sarcoma virus. Cancer Res., 47: 1325-1332, 1987.
25. Glasier, M. A., Wiebe, J. P., and Hobkirk, R. Progesterone metabolism by guinea pig intrauterine tissues. J. Steroid Biochem. Mol. Biol., 51: 199-207, 1994.
26. Wiebe, J. P., Boushy, D., and Wolfe, M. Synthesis, metabolism, and levels of the neuroactive steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), in rat pituilaries. Brain Res., 764: 158-166, 1997.
27. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res., 50: 6075-6086, 1990.
28. Engel, L. W., Young, N. A., Tralka, T. S., Lippman, M. E., O'Brien, S. J., and Joyce, J. J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res., 38: 3352-3364, 1978.
29. Jenkins, J. S., and Ash, S. Metabolism of testosterone by human breast tumours. Lancet, 2: 513-514, 1972.
30. Abul-Hajj, Y. J. Aromatization of androgens by human breast cancer. Steroids, 33: 205-222, 1979.
31. Li, K., and Adams, J. B. Aromatization of testosterone and oestrogen receptor levels in human breast cancer. J. Steroid Biochem., 14: 269-272, 1981.
32. Miller, W. R., and O'Neill, J. The importance of local synthesis of estrogen within the breast. Steroids, 50: 537-548, 1987.
33. Adams, J, B. Enzymatic regulation of estradiol-17β concentrations in human breast cancer cells. Breast Cancer Res. Treat., 20: 145-154, 1991.
34. Li. K., and Foo, T. Products of dehyroepiandrosterone metabolism by human mammary tumors and their influence on estradiol receptor binding. Steroids, Steroids, 31: 113-127, 1978.
35. Pasqualini, J. R., Gelly, C., Nguyen, B. L., and Vella, C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem., 14: 155-163, 1989.
36. Follow, K., Buquoi, E., Bauman, J., Schmidt-Gollwitzer, M., and Pollow, B. Comparison of the in vitro conversion of estradiol to estrone of normal and neoplastic human breast tissue, Mol. Cell. Endocrinol., 6. 333-348, 1977.
37. Telang, N. T., Axelrod, D. M., Wong, G. Y., Bradlow, H. L., and Osborne, M. P. Biotransformation of estradiol by explant culture of human mammary tissue. Steroids, 56: 37-43, 1991.
38. Hoffman, A. R., Paul, S. M., and Axelrod, J. Catechol-estrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res., 39: 4584-4587, 1979.
39. Lloyd, R. V. Studies on the progesterone receptor content and steroid metabolism in normal and pathological human breast tissues. J. Clin. Endocrinol. Metab., 48: 585-593, 1979.
40. Wiebe, J. P., de Gannes, G. C., and Dallaire, M. J. Synthesis of the allylic regulatory steroid, 3α-hydroxy-4-pregnen-20-one, by rat granulosa cells and its regulation by gonadotropins, Biol. Reprod., 50: 956-964, 1994.
41. Mori, M., Tomnaga, T., and Tamaoki, B. Steroid metabolism in the normal mammary gland and in dimethylbenzanthracene-induced mammary tumor of rats. Endocrinology, 102: 1387-1397, 1978.
42. Miller, W. R. Pathways of hormone metabolism in normal and non-neoplastic breast tissue. Ann. NY Acad. Sci., 586: 53-59, 1990.
43. Nuti, K. M., and Karavolas, H. J. Effect of progesterone and its 5α-reduced metabolites on gonadotropin levels in estrogen-primed ovariectomized rats. Endocrinology, 100: 777-781, 1977.
44. Majewska, M. D., Harrison, N. L., Schwarz, R. D., Barker, J. L., and Paul, S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science, 232:1004-1007, 1986.
45. Wiebe, J. P., and Kavaliers, M. Analgesic effects of the FSH-suppressing gonadal steroid, 3α-hydroxy-4-pregnen-20-one: possible modes of action. Brain Res., 461: 150-157, 1988.
46. Dhanvantari, S., and Wiebe, J. P. Suppression of FSH by the neurosteroid, 3α-hydroxy-4-pregnen-20-one, involves actions at the level of the gonadotrope membrane/calcium channel. Endocrinology, 134: 371-376, 1994.
47. Beck, C., Wolfe, M., Murphy, L., and Wiebe, J. P. Acute, nongenomic actions of the neuroactive gonadal steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), on FSH release in perfused rat anterior pituitary cells. Endocrine, 6: 221-229, 1997.
48. Wiebe, J. P. Nongenomic actions of steroids on gonadotropin release. Rec. Prog. Horm. Res., 52:71-101, 1997.
49. Anderson, T. J. Effects on breast tissue of exogenous oestrogens and progestogens. Acta Obstet. Gynecol. Scand. Suppl., 134: 9-13, 1986.
50. Schneider, H. P. G., and Jackisch, C. Potential benefits of estrogens and progestogens on breast cancer. Int. J. Fertil., 43: 278-285, 1998.
51. Soderqvist, G. Effects of sex steroids on proliferation in normal mammary tissue. Ann. Med., 30: 511-524, 1998.
52. Gompel, A., Malet, C., Spritzer, P., Lalardrie, J-P., Kuttenn, F., and Mauvais-Jarvis, P. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J. Clin. Endocrinol. Metab., 63: 1174-1180, 1986.
53. Jones, B., and Russo, J. Influences of steroid hormones on the growth fraction of human breast carcinoma. Am. J. Clin. Pathol., 88: 132-138, 1987.
54. Cummings, S. R. Evaluating the benefits and risks of postmenopausal hormone therapy. Am. J. Med., 91: 14S-18S. 1991.
55. Schroder, F. H. 5α-Reductase inhibitors and prostatic disease. Clin. Endocrinol., 41: 139-147, 1994.
56. Raz, A. Adhesive properties of metastasizing tumour cells. Ciba Found. Symp., 141: 109-122, 1988.
57. van de Stolpe, A., Caldenhoven, E., Raajmakers, J. A., van der Saag, P. T., and Koenderman, L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am. J. Respir. Cell Mol. Biol., 8: 340-347, 1993.
58. Gronowicz, G. A., and McCarthy, M. B. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease β1-integrin levels. Endocrinology, 136: 598-608, 1995.
59. Pearson, D., and Sheldon, P. Effect of corticosteroids on lymphocyte adhesion. Adv. Exp. Med. Biol., 371A: 167-170, 1995.
60. 3. J. Biol. Chem., 262: 4165-4171, 1987.
61. Segaert, S., Garmyn, M., Degreef, H., and Bouillon, R. Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes. J. Investig. Dermatol., 111: 551-558, 1998.
62. McCrohon, J. A., Jessup, W., Handelsman, D. J., and Celermajer, D. S. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation, 99: 2317-2322, 1999.
63. Sapiro, A., Pietribiasi, F., Bussolati, G., and Marchisio, P. C. Estrogen-and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. Cancer Res., 46: 2526-2531, 1986.
64. Fujimoto, J., Ichigo, S., Hori, M., Morishita, S., and Tamaya, T. Progestins and Danazol effect on cell-to-cell adhesion, and E-cadherin and α-and β-catenin mRNA expressions. J. Steroid Biochem. Mol. Biol., 57: 275-282, 1996.
65. Simoncini, T., De Caterina, R., and Genazzani, A. R. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Clin. Endocrinol. Metab., 84: 815-818, 1999.
66. Peluso, J. J., and Pappalardo, A. Progesterone and cell-cell adhesion interact to regulate rat granulosa cell apoptosis. Biochem. Cell Biol., 72: 547-551, 1994.
67. Shi, Y. E., Liu, Y. E., Lippman, M. E., and Dickson, R. B. Progestins and antiprogestins in mammary tumour growth and metastasis. Hum. Reprod., 9 (Suppl. 1): 162-173, 1994.
68. Chen, G. T., Getsios, S., and MacCalman, C. D. 17β-Estradiol potentiates the stimulatory effects of progesterone on cadherin-11 expression in cultured human endometrial stromal cells. Endocrinology, 139: 3512-3519, 1998.